Prognostic Value of Lymphoid Infiltration and Aggregation in Cervical Cancer.

Area of Science:

• Oncology
• Immunology
• Cancer Research

Background:

• Understanding the immune microenvironment is crucial for developing effective cervical cancer therapeutics.
• Early-stage cervical cancer often recurs, necessitating identification of prognostic markers.
• Immune cell aggregates, including lymphoid aggregates (LAs) and tertiary lymphoid structures (TLSs), play a role in anti-tumor immunity.

Purpose of the Study:

• To investigate the immune microenvironment in early-stage cervical cancer.
• To analyze the spatial organization and prognostic significance of B and T cell immune aggregates.
• To identify potential biomarkers for predicting recurrence and survival.

Main Methods:

• Multispectral imaging was used to analyze T and B cell location and organization in early-stage cervical cancer patient cohorts.
• Immune cell infiltration, lymphoid aggregate (LA) and tertiary lymphoid structure (TLS) presence, and chemokine CXCL13 levels were quantified.
• Validation was performed using The Cancer Genome Atlas (TCGA) cohort.

Main Results:

• High CD8+ T cell infiltration correlated with improved overall survival (OS), especially in adenocarcinoma.
• CD8+ T cell and B cell colocalization suggested TLS formation, associated with better prognosis.
• High CXCL13 levels correlated with improved recurrence-free survival. Most immune structures were LAs, lacking features of developed TLS.
• Combined high CXCL13 and lymphoid structures predicted improved OS. TCGA validation confirmed survival trends.

Conclusions:

• Immune cell infiltration and TLS induction have prognostic significance in early cervical cancer.
• The presence and organization of immune aggregates, particularly TLSs, are important indicators of patient outcomes.
• CXCL13 and specific immune structures represent potential therapeutic targets for enhancing anti-tumor immunity.